Responses
Other responses
Jump to comment:
- Published on: 3 April 2006
- Published on: 27 March 2006
- Published on: 6 March 2006
- Published on: 3 April 2006Corneal calcification associated with the use of topical phosphate containing preparationShow More
Dear Editor,
We read with great interest the article by Bernauer et al [1] on the use hyaluronate artificial tear formulation �Hylo-Comod� favours the formation of corneal calcification related to the phosphate content of eye medications and frequent instillation. We agree with their conclusion and would like to highlight that in the setting of dry chronically inflamed eyes phosphate containing topical preparati...
Conflict of Interest:
None declared. - Published on: 27 March 2006Author replyShow More
Dear Editor,
Thank you for writing and giving us the opportunity to further comment on our case series and investigations. We wish to put several misquotations right, respond to the accusation of inappropriate dosage, comment on the declaration of ingredients, explain our case description and substantiate the necessity to publish this case series.
Please note that we described five and not six cases. The...
Conflict of Interest:
None declared. - Published on: 6 March 2006Phosphate on the cornea: The dose makes the poison.Show More
Dear Editor,
The article by Bernauer et al. takes a new focus on the topic of corneal calcification related to the phosphate content of eye medications. This topic has been addressed previously by our group, first with the observation in glaucoma patients published by Huige et al. (1) then on the normal eye (2), and finally on patients with eye burns receiving phosphate buffer treatment(3). Other reports of non ph...
Conflict of Interest:
None declared.